| | |
SMD
|
LL
|
HL
|
Degrees of freedom
|
Heterogeneity
|
Effect size
|
|---|
|
I2
|
Z
|
P
|
|---|
|
Species
|
SR
|
−3.33
|
−5.18
|
−1.47
|
5
|
92.10%
|
3.52
|
P < 0.00001
|
|
WR
|
−2.85
|
−3.79
|
−1.91
|
5
|
73.50%
|
5.93
|
P = 0.002
|
|
Modeling
|
2-VO
|
−2.97
|
−4.21
|
− 1.73
|
6
|
85.80%
|
4.69
|
P < 0.00001
|
|
4-VO
|
−3.36
|
−8.63
|
1.92
|
1
|
94.30%
|
1.25
|
P = 0.212
|
|
EO
|
−2.38
|
−3.82
|
−0.95
|
1
|
65.80%
|
3.26
|
P = 0.001
|
|
MCAO
|
−5.19
|
−6.58
|
−3.79
|
0
|
–
|
7.29
|
P < 0.00001
|
|
Methods
|
EA
|
−3.05
|
−4.56
|
−1.53
|
6
|
90.50%
|
3.94
|
P < 0.00001
|
|
MA
|
−3.11
|
−4.23
|
−2.00
|
4
|
75.90%
|
5.47
|
P = 0.002
|
|
OVERALL
|
−3.06
|
−4.04
|
−2.09
|
11
|
87.10%
|
6.04
|
P < 0.00001
|
- SR Sprague–Dawley Rats, WR Wister Rats, 2-VO bilateral common carotid artery occlusion, VO 4-vessel occlusion, EO embolic occlusion, MCAO middle cerebral artery occlusion, EA Electroacupuncture, MA Manual acupuncture
